Skip to main content
Advanced Enzyme Technologies Limited logo

Advanced Enzyme Technologies Limited — Investor Relations & Filings

Ticker · ADVENZYMES ISIN · INE837H01020 LEI · 335800PWJRERMBTUUV90 BSE.NS Manufacturing
Open in API
Filings indexed 938 across all filing types
Latest filing 2025-05-13 Regulatory Filings
Country IN India
Listing BSE.NS ADVENZYMES

About Advanced Enzyme Technologies Limited

https://www.advancedenzymes.com/

Advanced Enzyme Technologies Limited is a research-driven company specializing in the development, manufacturing, and marketing of proprietary enzyme products and probiotics. The company operates across the entire enzyme value chain, from research and development to commercial-scale production. Its diverse portfolio serves multiple sectors, including human nutrition, animal nutrition, and industrial processing. Key applications encompass food and beverage production, dietary supplements, animal feed additives, and various industrial processes such as textiles, detergents, and pulp and paper manufacturing. With a focus on biotechnology and sustainable solutions, the firm leverages its extensive R&D capabilities to provide customized enzyme formulations. The company maintains a global footprint, supplying specialized biological solutions to a broad international client base.

Recent filings

Filing Released Lang Actions
Dividend
Regulatory Filings
2025-05-13 English
Outcome of Board Meeting
Regulatory Filings
2025-05-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification about an upcoming conference call to discuss the financial results for the quarter and year ended March 31, 2025. It is an intimation or announcement of the event, not the transcript or the financial results themselves. The document is short (2704 characters) and serves to inform stakeholders about the call details, including date, time, and dial-in numbers. According to the rules, announcements of conference calls are classified as Call Transcript (CT) only if they contain the full transcript. Since this is only an announcement of the call, it does not qualify as a transcript. It is also not a report publication announcement (RPA) because it does not mention the report being attached or published. The best fitting category is Regulatory Filings (RNS) as a general regulatory announcement about the conference call event.
2025-05-09 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-05-06 English
Record Date
Regulatory Filings Classification · 95% confidence The document is a notice informing about a scheduled Board Meeting to consider and approve the annual financial statements for the fiscal year ended March 31, 2025, and to consider dividend declarations. It also mentions the record date for interim dividend and closure of the trading window. The document does not contain the financial statements or detailed financial data itself but is an announcement of an upcoming board meeting and related corporate actions. The document length is short (1924 characters) and it serves as an intimation or notice rather than a full report. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and notices that do not fit other specific categories.
2025-05-06 English
Board Meeting — Financial Results/Dividend
Regulatory Filings Classification · 95% confidence The document is a notice dated May 6, 2025, informing about a scheduled Board Meeting on May 13, 2025. The agenda includes consideration and approval of annual financial statements for the year ended March 31, 2025, and declaration of dividends. It also mentions the record date for interim dividend and closure of the trading window. The document is an announcement of an upcoming board meeting and related corporate actions, not the actual financial report or dividend declaration. The document length is short (1924 characters) and serves as an intimation or notice rather than a full report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and notice to stock exchanges and shareholders.
2025-05-06 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.